{"id":"W2971156007","doi":"10.1055/s-0039-1695771","title":"Global Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance Program","year":2019,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Idarucizumab; Medicine; Dabigatran; Interquartile range; Postmarketing surveillance; Surgery; Emergency medicine; Adverse effect; Internal medicine; Warfarin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003986634,0.0002266556,0.0004271006,0.00167227,0.0003039768,0.001482226,0.0007077112,0.0005113376,0.0008823848],"category_scores_gemma":[0.01281069,0.0002528083,0.0004913091,0.002900644,0.0005956276,0.001321373,0.001405271,0.0008659372,0.0003147718],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009900305,"about_ca_system_score_gemma":0.001364226,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007216334,"about_ca_topic_score_gemma":0.007206941,"domain_scores_codex":[0.9964613,0.001123362,0.0006173303,0.000649977,0.0007427941,0.000405178],"domain_scores_gemma":[0.9731786,0.002502964,0.01827577,0.0008835007,0.002782548,0.002376585],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00007212081,0.00003894839,0.9977858,0.00001965416,0.00003411649,0.00001946026,0.000100324,0.00003050193,0.00002572545,0.00002332432,0.0002834287,0.001566677],"study_design_scores_gemma":[0.00002321756,0.0002027938,0.9982364,0.00004194537,0.00002962544,0.0001850515,0.0004195475,0.0003223738,0.00005747639,0.00002788861,0.0004467261,0.000006864766],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952148,0.0006905274,0.0001394947,0.0003551384,0.00001112334,0.00006095245,0.002226913,0.00001229066,0.001288804],"genre_scores_gemma":[0.9973884,0.0003035121,0.000141313,0.0001531444,0.00002337708,0.00003328689,0.001825585,0.000006832422,0.0001245216],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007216334,"threshold_uncertainty_score":0.02108353,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1816228507043575,"score_gpt":0.4594964860130357,"score_spread":0.2778736353086782,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}